Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics
dc.contributor.author | Lozhkin, A | |
dc.contributor.author | Vendrov, AE | |
dc.contributor.author | Ramos-Mondragón, R | |
dc.contributor.author | Canugovi, C | |
dc.contributor.author | Stevenson, MD | |
dc.contributor.author | Herron, TJ | |
dc.contributor.author | Hummel, SL | |
dc.contributor.author | Figueroa, CA | |
dc.contributor.author | Bowles, DE | |
dc.contributor.author | Isom, LL | |
dc.contributor.author | Runge, MS | |
dc.contributor.author | Madamanchi, NR | |
dc.coverage.spatial | Netherlands | |
dc.date.accessioned | 2022-11-10T15:16:11Z | |
dc.date.available | 2022-11-10T15:16:11Z | |
dc.date.issued | 2022-11-01 | |
dc.identifier.issn | 2213-2317 | |
dc.identifier.issn | 2213-2317 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/36183542 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175138 | en |
dc.description.abstract | Diastolic dysfunction (DD) underlies heart failure with preserved ejection fraction (HFpEF), a clinical syndrome associated with aging that is becoming more prevalent. Despite extensive clinical studies, no effective treatment exists for HFpEF. Recent findings suggest that oxidative stress contributes to the pathophysiology of DD, but molecular mechanisms underpinning redox-sensitive cardiac remodeling in DD remain obscure. Using transgenic mice with mitochondria-targeted NOX4 overexpression (Nox4TG618) as a model, we demonstrate that NOX4-dependent mitochondrial oxidative stress induces DD in mice as measured by increased E/E′, isovolumic relaxation time, Tau Glantz and reduced dP/dtmin while EF is preserved. In Nox4TG618 mice, fragmentation of cardiomyocyte mitochondria, increased DRP1 phosphorylation, decreased expression of MFN2, and a higher percentage of apoptotic cells in the myocardium are associated with lower ATP-driven and maximal mitochondrial oxygen consumption rates, a decrease in respiratory reserve, and a decrease in citrate synthase and Complex I activities. Transgenic mice have an increased concentration of TGFβ and osteopontin in LV lysates, as well as MCP-1 in plasma, which correlates with a higher percentage of LV myocardial periostin- and ACTA2-positive cells compared with wild-type mice. Accordingly, the levels of ECM as measured by Picrosirius Red staining as well as interstitial deposition of collagen I are elevated in the myocardium of Nox4TG618 mice. The LV tissue of Nox4TG618 mice also exhibited increased ICaL current, calpain 2 expression, and altered/disrupted Z-disc structure. As it pertains to human pathology, similar changes were found in samples of LV from patients with DD. Finally, treatment with GKT137831, a specific NOX1 and NOX4 inhibitor, or overexpression of mCAT attenuated myocardial fibrosis and prevented DD in the Nox4TG618 mice. Together, our results indicate that mitochondrial oxidative stress contributes to DD by causing mitochondrial dysfunction, impaired mitochondrial dynamics, increased synthesis of pro-inflammatory and pro-fibrotic cytokines, activation of fibroblasts, and the accumulation of extracellular matrix, which leads to interstitial fibrosis and passive stiffness of the myocardium. Further, mitochondrial oxidative stress increases cardiomyocyte Ca2+ influx, which worsens CM relaxation and raises the LV filling pressure in conjunction with structural proteolytic damage. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation.haspart | ARTN 102474 | |
dc.rights | Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Cardiomyocyte | |
dc.subject | Diastolic dysfunction | |
dc.subject | Heart failure with preserved ejection fraction | |
dc.subject | Interstitial fibrosis | |
dc.subject | Mitochondrial dysfunction | |
dc.subject | NADPH oxidase 4 | |
dc.subject | NOX4 inhibitor | |
dc.title | Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics | |
dc.type | Article | |
dc.identifier.pmid | 36183542 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175138/2/Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics.pdf | |
dc.identifier.doi | 10.1016/j.redox.2022.102474 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6599 | |
dc.identifier.source | Redox Biology | |
dc.description.version | Published version | |
dc.date.updated | 2022-11-10T15:16:02Z | |
dc.identifier.orcid | 0000-0003-4971-8040 | |
dc.identifier.orcid | 0000-0002-0924-3135 | |
dc.identifier.orcid | 0000-0002-9479-6729 | |
dc.identifier.orcid | 0000-0003-0590-0908 | |
dc.description.filedescription | Description of Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics.pdf : Published version | |
dc.identifier.volume | 57 | |
dc.identifier.startpage | 102474 | |
dc.identifier.name-orcid | Lozhkin, A | |
dc.identifier.name-orcid | Vendrov, AE; 0000-0003-4971-8040 | |
dc.identifier.name-orcid | Ramos-Mondragón, R | |
dc.identifier.name-orcid | Canugovi, C | |
dc.identifier.name-orcid | Stevenson, MD | |
dc.identifier.name-orcid | Herron, TJ | |
dc.identifier.name-orcid | Hummel, SL; 0000-0002-0924-3135 | |
dc.identifier.name-orcid | Figueroa, CA | |
dc.identifier.name-orcid | Bowles, DE | |
dc.identifier.name-orcid | Isom, LL; 0000-0002-9479-6729 | |
dc.identifier.name-orcid | Runge, MS | |
dc.identifier.name-orcid | Madamanchi, NR; 0000-0003-0590-0908 | |
dc.working.doi | 10.7302/6599 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.